Holding(s) in Company

RNS Number : 0288Y
Surgical Innovations Group PLC
23 February 2012



Surgical Innovations Group plc

(the "Company")

Holding in Company



Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of innovative medical devices, announces that it was notified today, Thursday 23 February, that as at 17 February 2012, Mr. C W N John has a beneficial interest in the Company of 36,304,124 ordinary shares of 1p each, representing 9.22 per cent. of the issued ordinary share capital.


- Ends -





Surgical Innovations Group plc


Doug Liversidge, Non-Executive Chairman

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597


Seymour Pierce Limited


Freddy Crossley / Sarah Jacobs

Tel: +44 (0) 20 7107 8000

Corporate Broking

David Banks/ Jacqui Briscoe

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893


Fiona Henson

Mob: 07886 335 992




Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of 45 distribution partners, Surgical Innovations branded products are sold in all major medical markets including North America, Europe, South Africa, the Middle East, South-east Asia and Australia. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, collecting sales fees as well as IP license and royalty fees.  Clients include Teleflex Medical, Gyrus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, such as turbines, in situ with minimum disassembly and downtime. 


For more information, see www.surginno.com


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings